Articles Tagged With: pembrolizumab
-
Checkpoint Inhibitors: The First Effective Therapy for Progressive Multifocal Leukoencephalopathy?
Enhancing the immune response with checkpoint inhibitors may be beneficial in the management of progressive multifocal leukoencephalopathy, a viral disease previously recalcitrant to therapy.
-
Treatment of Progressive Multifocal Leukoencephalopathy With Pembrolizumab
These authors evaluated the effect of pembrolizumab, a monoclonal antibody that functions as a down-regulator of PD-1 (programmed cell death protein 1), on patients with progressive multifocal leukoencephalopathy. In five of eight treated patients, clinical stabilization or improvement was seen in association with reduced cerebrospinal fluid JC viral load. This is the first reported effective treatment for this disease with a therapeutic agent targeting the JC virus.